Vertex Pharmaceuticals Incorporated Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
CAPITAL WORLD INVESTORS | 02/13/2025 | 28.33 M | $11.41 B | 5.65% | 11.00% |
VANGUARD GROUP INC | 02/11/2025 | 23.26 M | $9.37 B | 0.43% | 9.03% |
BLACKROCK, INC. | 02/07/2025 | 21.83 M | $8.79 B | 0.17% | 8.48% |
STATE STREET CORP | 02/14/2025 | 11.98 M | $4.82 B | 1.38% | 4.64% |
CAPITAL RESEARCH GLOBAL INVESTORS | 02/13/2025 | 10.43 M | $4.20 B | 15.85% | 4.05% |
FMR LLC | 02/13/2025 | 9.22 M | $3.71 B | -12.41% | 3.58% |
JPMORGAN CHASE & CO | 02/12/2025 | 6.31 M | $2.54 B | -8.88% | 2.45% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 5.92 M | $2.38 B | 23.28% | 2.30% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 5.65 M | $2.27 B | -4.85% | 2.19% |
JENNISON ASSOCIATES LLC | 01/24/2025 | 4.32 M | $1.74 B | -22.21% | 1.68% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 3.92 M | $1.58 B | -46.83% | 1.52% |
LOOMIS SAYLES & CO L P | 02/12/2025 | 3.77 M | $1.52 B | 22.96% | 1.47% |
NORGES BANK | 02/12/2025 | 3.41 M | $1.37 B | 100.00% | 1.33% |
AMUNDI | 02/07/2025 | 3.28 M | $1.35 B | -12.72% | 1.27% |
MORGAN STANLEY | 02/14/2025 | 3.17 M | $1.28 B | 4.38% | 1.23% |
EDGEWOOD MANAGEMENT LLC | 02/13/2025 | 2.96 M | $1.19 B | 91.20% | 1.15% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 2.83 M | $1.14 B | 12.60% | 1.10% |
NORTHERN TRUST CORP | 02/14/2025 | 2.72 M | $1.10 B | 15.01% | 1.06% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 2.42 M | $974.27 M | -7.27% | 0.94% |
UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 2.33 M | $937.98 M | -4.60% | 0.90% |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 02/12/2025 | 2.29 M | $921.58 M | -21.24% | 0.89% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 2.02 M | $811.64 M | 7.68% | 0.78% |
INVESCO LTD. | 02/13/2025 | 1.90 M | $764.51 M | -2.32% | 0.74% |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 1.88 M | $758.75 M | -1.11% | 0.73% |
CLEARBRIDGE INVESTMENTS, LLC | 02/12/2025 | 1.85 M | $745.34 M | -6.15% | 0.72% |
PARNASSUS INVESTMENTS, LLC | 02/10/2025 | 1.82 M | $731.28 M | 100.00% | 0.71% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 1.76 M | $708.44 M | -1.54% | 0.68% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.69 M | $680.85 M | -4.37% | 0.66% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.66 M | $670.03 M | 2.31% | 0.65% |
ROYAL BANK OF CANADA | 02/14/2025 | 1.45 M | $584.30 M | -7.44% | 0.56% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.40 M | $564.48 M | 3.18% | 0.54% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.40 M | $562.66 M | -14.36% | 0.54% |
DEUTSCHE BANK AG\ | 02/14/2025 | 1.39 M | $559.59 M | 5.84% | 0.54% |
WCM INVESTMENT MANAGEMENT, LLC | 02/11/2025 | 1.09 M | $435.90 M | 100.00% | 0.42% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 1.05 M | $423.28 M | 33.18% | 0.41% |
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 02/14/2025 | 970,662 | $390.89 M | -6.42% | 0.38% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 04/23/2025 | 880,214 | $354.46 M | -9.05% | 0.34% |
HSBC HOLDINGS PLC | 02/14/2025 | 873,755 | $351.73 M | 2.19% | 0.34% |
UBS GROUP AG | 02/14/2025 | 863,036 | $347.54 M | 11.47% | 0.33% |
BARCLAYS PLC | 02/13/2025 | 843,075 | $339.51 M | -10.25% | 0.33% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 839,672 | $338.14 M | 169.43% | 0.33% |
HARDING LOEVNER LP | 02/14/2025 | 823,627 | $331.67 M | -28.54% | 0.32% |
FRANKLIN RESOURCES INC | 02/12/2025 | 760,517 | $306.26 M | 59.49% | 0.30% |
SWISS NATIONAL BANK | 02/10/2025 | 729,200 | $293.65 M | -4.80% | 0.28% |
VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 698,706 | $281.25 M | -25.52% | 0.27% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 689,652 | $277.72 M | -16.93% | 0.27% |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/12/2025 | 664,523 | $267.60 M | 20.76% | 0.26% |
SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/28/2025 | 659,533 | $265.59 M | -1.87% | 0.26% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 627,517 | $252.68 M | -3.13% | 0.24% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 596,555 | $240.23 M | 34.73% | 0.23% |
Vertex Pharmaceuticals Incorporated institutional Ownership - FAQ's
During the previous two years, 1683 institutional investors and hedge funds held shares of Vertex Pharmaceuticals Incorporated. The most heavily invested institutionals were:
Catalina Capital Group, LLC: 0
PATTON FUND MANAGEMENT, INC.: 0
Synergy Asset Management, LLC: 0
LECAP ASSET MANAGEMENT LTD: 0
WORLD EQUITY GROUP, INC.: 0
Columbia Asset Management: 0
91.57% of Vertex Pharmaceuticals Incorporated stock is owned by institutional investors.
Institutional investors have bought a total of 293.00 M shares in the last 24 months. This purchase volume represents approximately $144.26 B in transactions.